Skip to main content
Top
Published in: Drugs & Aging 10/2005

01-10-2005 | Current Opinion

Asymptomatic Bacteriuria in Elderly Patients

Significance and Implications for Treatment

Authors: Dr Florian M. E. Wagenlehner, Kurt G. Naber, Wolfgang Weidner

Published in: Drugs & Aging | Issue 10/2005

Login to get access

Abstract

Asymptomatic bacteriuria (ASB) is frequent in elderly patients and even more prevalent in residents of long-term care facilities. Furthermore, because more and more people are reaching advanced age and the need for care increases with age, ASB is becoming increasingly important.
There are several definitions for ASB, all of which require positive urine cultures and place little or no importance on accompanying pyuria. Most ASB is associated with complicating factors, as might be found in complicated urinary tract infections (UTIs). Thus, the bacterial spectrum associated with ASB is comparable to that seen in complicated UTIs. A variety of complicating factors are more frequently found in elderly patients with ASB, such as hormonal factors (e.g. estrogen decrease), certain anatomical factors (e.g. prostate obstruction), metabolic factors (e.g. diabetes mellitus), functional alteration of the urinary bladder, immunological changes and a high rate of indwelling-catheter use.
Screening for ASB in elderly people is limited to those undergoing invasive urological procedures and surgical procedures with implant material. In other situations, examination of the urine is not recommended if signs or symptoms in the urinary tract are absent.
Treatment of ASB is recommended only before urological procedures. Pyuria accompanying ASB is not an indication for antimicrobial treatment. If antimicrobial treatment is considered, concomitant factors that occur frequently in elderly people, such as renal insufficiency, must be taken into account.
Although ASB is apparently a benign condition, prevention in elderly people is important. The degree of pathogenicity of bacteria causing ASB has not yet been satisfactorily elucidated. Therefore, until the implications of the bacteria involved in ASB are fully understood, implementing the same hygienic precautions as are used in individuals with symptomatic UTIs should at least be undertaken.
Literature
1.
go back to reference Gomolin IH, McCue JD. Urinary tract infection in the elderly patient. Infect Urol 2000; 13Suppl. 5a: 7–13 Gomolin IH, McCue JD. Urinary tract infection in the elderly patient. Infect Urol 2000; 13Suppl. 5a: 7–13
2.
go back to reference Baldassarre JS, Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am 1991; 75: 375–90PubMed Baldassarre JS, Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am 1991; 75: 375–90PubMed
3.
go back to reference Boscia JA, Kobasa WD, Knight RA, et al. Epidemiology of bacteriuria in an elderly ambulatory population. Am J Med 1986; 80: 208–14PubMedCrossRef Boscia JA, Kobasa WD, Knight RA, et al. Epidemiology of bacteriuria in an elderly ambulatory population. Am J Med 1986; 80: 208–14PubMedCrossRef
4.
go back to reference Nicolle LE. Urinary tract infections in the elderly: symptomatic or asymptomatic? Int J Antimicrobiol Agents 1999; 11: 265–8CrossRef Nicolle LE. Urinary tract infections in the elderly: symptomatic or asymptomatic? Int J Antimicrobiol Agents 1999; 11: 265–8CrossRef
5.
go back to reference Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001; 22: 316–21PubMedCrossRef Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001; 22: 316–21PubMedCrossRef
6.
go back to reference Weidner W, Hochreiter W, Liedl B, et al. Urogenitale Infektionen im Alter. Urologe A 2002; 41: 328–32PubMedCrossRef Weidner W, Hochreiter W, Liedl B, et al. Urogenitale Infektionen im Alter. Urologe A 2002; 41: 328–32PubMedCrossRef
7.
go back to reference Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69: 56–64PubMed Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69: 56–64PubMed
8.
go back to reference Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40PubMedCrossRef Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40PubMedCrossRef
9.
go back to reference Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–54PubMedCrossRef Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–54PubMedCrossRef
10.
go back to reference Nicolle LE. Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice. CMAJ 2000; 163: 285–6PubMed Nicolle LE. Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice. CMAJ 2000; 163: 285–6PubMed
11.
go back to reference Raz R. Asymptomatic bacteriuria: clinical significance and management. Int J Antimicrob Agents 2003; 22: 45–7PubMedCrossRef Raz R. Asymptomatic bacteriuria: clinical significance and management. Int J Antimicrob Agents 2003; 22: 45–7PubMedCrossRef
12.
go back to reference Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2003; 21: 605–21PubMedCrossRef Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2003; 21: 605–21PubMedCrossRef
13.
go back to reference Hull AR, Donovan WH, Del Terzo M, et al. Role of type 1 fimbria- and p fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 2002; 70: 6481–4PubMedCrossRef Hull AR, Donovan WH, Del Terzo M, et al. Role of type 1 fimbria- and p fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 2002; 70: 6481–4PubMedCrossRef
14.
go back to reference Hultgren SJ, Porter TN, Schaeffer AJ, et al. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 1985; 50: 370–7PubMed Hultgren SJ, Porter TN, Schaeffer AJ, et al. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 1985; 50: 370–7PubMed
15.
go back to reference Wullt B, Bergsten G, Connell H, et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 2000; 38: 456–64PubMedCrossRef Wullt B, Bergsten G, Connell H, et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 2000; 38: 456–64PubMedCrossRef
16.
go back to reference Johnson JR. Host-pathogen interactions in Escherichia coli urinary tract infections. Curr Opin Infect Dis 1994; 7: 287–94CrossRef Johnson JR. Host-pathogen interactions in Escherichia coli urinary tract infections. Curr Opin Infect Dis 1994; 7: 287–94CrossRef
17.
go back to reference Wagenlehner FME, Niemetz A, Dalhoff A, et al. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrob Agents 2002; 19: 557–64PubMedCrossRef Wagenlehner FME, Niemetz A, Dalhoff A, et al. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrob Agents 2002; 19: 557–64PubMedCrossRef
18.
go back to reference Wagenlehner FM, Naber KG. Antibiotics and resistance of uropathogens. Eur Urol 2004; 2: 125–35 Wagenlehner FM, Naber KG. Antibiotics and resistance of uropathogens. Eur Urol 2004; 2: 125–35
19.
go back to reference George NJR. Urinary tract infection. In: Mundy AR, Fitzpatrick JM, Neal DE, et al., editors. The scientific basis of urology. Oxford: ISIS medical media, 1999 George NJR. Urinary tract infection. In: Mundy AR, Fitzpatrick JM, Neal DE, et al., editors. The scientific basis of urology. Oxford: ISIS medical media, 1999
20.
go back to reference Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723–5PubMedCrossRef Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723–5PubMedCrossRef
21.
go back to reference Geerlings SE, Stolk RP, Camps MJL, et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000; 23: 1737–41PubMedCrossRef Geerlings SE, Stolk RP, Camps MJL, et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000; 23: 1737–41PubMedCrossRef
22.
go back to reference Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2000; 17: 287–92CrossRef Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2000; 17: 287–92CrossRef
23.
go back to reference Hoepelmann AIM, Meiland R, Geerlings S. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 2003; 22: 35–43CrossRef Hoepelmann AIM, Meiland R, Geerlings S. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 2003; 22: 35–43CrossRef
24.
go back to reference Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687–99PubMedCrossRef Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687–99PubMedCrossRef
25.
go back to reference Orr PH, Nicolle LE, Duckworth H, et al. Febrile urinary infection in the institutionalized elderly. Am J Med 1996; 100: 71–7PubMedCrossRef Orr PH, Nicolle LE, Duckworth H, et al. Febrile urinary infection in the institutionalized elderly. Am J Med 1996; 100: 71–7PubMedCrossRef
26.
go back to reference Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among male nursing home patients: a prospective study. J Urol 1987; 138: 1191–5PubMed Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among male nursing home patients: a prospective study. J Urol 1987; 138: 1191–5PubMed
27.
go back to reference Warren JW, Munci HL, Hall-Craggs M. Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study. J Infect Dis 1988; 158: 1341–6PubMedCrossRef Warren JW, Munci HL, Hall-Craggs M. Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study. J Infect Dis 1988; 158: 1341–6PubMedCrossRef
28.
29.
go back to reference Harding KM, Zhanel GG, Nicolle LE, et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576–83PubMedCrossRef Harding KM, Zhanel GG, Nicolle LE, et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576–83PubMedCrossRef
30.
go back to reference Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 2001; 18: 837–51PubMedCrossRef Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 2001; 18: 837–51PubMedCrossRef
31.
go back to reference Naber KG, Fünfstück R, Hofstetter A, et al. Empfehlungen zur antimikrobiellen Therapie von Infektionen der Nieren und des Urogenitaltraktes bei Erwachsenen. Chemotherapie Journal 2000; 6: 193–9 Naber KG, Fünfstück R, Hofstetter A, et al. Empfehlungen zur antimikrobiellen Therapie von Infektionen der Nieren und des Urogenitaltraktes bei Erwachsenen. Chemotherapie Journal 2000; 6: 193–9
32.
go back to reference Dettli L. Translation of pharmacokinetics to clinical medicine. J Pharmacokinet Biopharm 1973; 1: 403–18PubMed Dettli L. Translation of pharmacokinetics to clinical medicine. J Pharmacokinet Biopharm 1973; 1: 403–18PubMed
33.
go back to reference Kunin CM. A guide to the use of antibiotics in patients with renal disease: a table of recommended doses and factors governing serum levels. Am Intern Med 1967; 67: 151–8 Kunin CM. A guide to the use of antibiotics in patients with renal disease: a table of recommended doses and factors governing serum levels. Am Intern Med 1967; 67: 151–8
34.
go back to reference Vahlensieck Jr W. Prophylaxemaßnahmen bei rezidivierenden Harnwegsinfektionen. In: Hofstetter A, (Hrsg) Urogenitale Infektionen. Berlin: Springer, 1999: 215–239CrossRef Vahlensieck Jr W. Prophylaxemaßnahmen bei rezidivierenden Harnwegsinfektionen. In: Hofstetter A, (Hrsg) Urogenitale Infektionen. Berlin: Springer, 1999: 215–239CrossRef
35.
go back to reference Jepson RG, Mihaljevic L, Craig JC. Cranberries for preventing urinary tract infections (Cochrane review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2003 Jepson RG, Mihaljevic L, Craig JC. Cranberries for preventing urinary tract infections (Cochrane review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2003
36.
go back to reference Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: what is the evidence? Urology 2001; 57: 407–13PubMedCrossRef Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: what is the evidence? Urology 2001; 57: 407–13PubMedCrossRef
37.
go back to reference Lee B, Bhuta T, Craig J, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2002; (1): CD003265 Lee B, Bhuta T, Craig J, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2002; (1): CD003265
38.
go back to reference Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2002; (3): CD001535 Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2002; (3): CD001535
39.
go back to reference Mack DJ, Smart L, Girdwood A, et al. Infection prophylaxis with lactulose [letter]. Age Ageing 1993; 22Suppl. 2: 8CrossRef Mack DJ, Smart L, Girdwood A, et al. Infection prophylaxis with lactulose [letter]. Age Ageing 1993; 22Suppl. 2: 8CrossRef
40.
go back to reference McCutcheon J, Fulton JD. Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care. J Hosp Infect 1989; 13: 81–6PubMedCrossRef McCutcheon J, Fulton JD. Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care. J Hosp Infect 1989; 13: 81–6PubMedCrossRef
41.
go back to reference Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–6PubMedCrossRef Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–6PubMedCrossRef
Metadata
Title
Asymptomatic Bacteriuria in Elderly Patients
Significance and Implications for Treatment
Authors
Dr Florian M. E. Wagenlehner
Kurt G. Naber
Wolfgang Weidner
Publication date
01-10-2005
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 10/2005
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200522100-00001

Other articles of this Issue 10/2005

Drugs & Aging 10/2005 Go to the issue